Pages Menu
Categories Menu

Resource Links


ACTG Website

ACTG Drug Interactions Database

Centers for Disease Control (list of AIDS Defining Conditions)

DAIDS Adverse Event reporting

DAIDS Clinical Site Monitoring (CSM) Training Announcement Training Announcement

DAIDS Frequently Asked Questions Regarding DAERS


DAIDS PAB PEP Template Sample Completed DAIDS PAB PEP Template

DAIDS Regulatory and Pharmacovigilence

DAIDS Regulatory Support Center

DAIDS Required Site SOP Samples Sample Templates

FSTRF Portal


NHLBI AIDS Funding Opportunities

PPD Monitor MACE Training

We’re currently seeking study participants to take part in REPRIEVE. Please contact us to learn more.

Latest Tweets

reprievetrial @reprievetrial
REPRIEVE Trial  @reprievetrialThis @pozmagazine article examines the promising future of #HIV treatment, mentioning the REPRIEVE Trial 
REPRIEVE Trial  @reprievetrialToday is #NLAAD: #HIV increases the risk of heart disease. See how #NIH is addressing this problem 
REPRIEVE Trial  @reprievetrialRT @pozmagazine:Living longer with #HIV is a great thing- here's why it's important to know how aging and #HIV intersect 
REPRIEVE Trial  @reprievetrial#HIV raises your risk of heart disease-but researchers are testing if statins can help. Learn more at #WorldHeartDay 
REPRIEVE Trial  @reprievetrialDYK people with #HIV are up to 2x more likely to have a heart attack? Learn more at #WorldHeartDay